NASDAQ | ETF
The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser.
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| UMRX | Cogent Biosciences Inc | Healthcare | Biotechnology | 8.21% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 7.40% |
| LIVN | LivaNova PLC | Healthcare | Medical Devices | 6.54% |
| SYRE | Spyre Therapeutics Inc. | Healthcare | Biotechnology | 6.33% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 6.32% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 6.02% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 4.91% |
| ETNB | 89bio Inc | Healthcare | Biotechnology | 4.88% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 4.82% |
| KALV | Kalvista Pharmaceuticals Inc | Healthcare | Biotechnology | 4.58% |
| NKTR | Nektar Therapeutics | Healthcare | Biotechnology | 4.11% |
| TMDX | TransMedics Group Inc | Healthcare | Medical Devices | 4.04% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 3.98% |
| SVRA | Savara Inc | Healthcare | Biotechnology | 3.93% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.84% |
| TRVI | Trevi Therapeutics Inc | Healthcare | Biotechnology | 3.23% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.16% |
| ICUI | ICU Medical Inc | Healthcare | Medical Instruments & Supplies | 2.48% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.33% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 2.28% |